Saturday, 3 October 2026Updated 9m ago
← Market pulse
Order win▲ Bullish for Aurobindo Pharma

Aurobindo Pharma gets USFDA final approval for Perampanel tablets

1 source · first seen 18:53 3 Oct · updated 18:53 3 Oct

The brief

Written from 1 report · check the source before you trade
  • USFDA granted final approval for Aurobindo Pharma’s Perampanel tablets
  • Aurobindo plans to launch in Q3 FY27; estimated US market size is $67 million
  • The approval and launch plan could support Aurobindo Pharma’s US generics business

Tags on this story

Pick a tag to see all its stories
Aurobindo Pharma₹1,676.80 · 1 todayUSFDA3 todayPharma and healthcare10 today

Linked by the tag Aurobindo Pharma

5 stories this week
  1. 28 SeptUS exempts select Indian specialty drugs and ingredients from its 100% pharma tariffPolicy · 7 sources · The exemption covers certain specialty drugs and ingredients from India and 19 other countries
All Aurobindo Pharma stories →

Read the reports

1 report · earliest 18:53
CNBC-TV18Aurobindo Pharma gets USFDA final approval for Perampanel tablets18:53